New Development Targets Prevention of Severe Respiratory Syncytial Virus Infections The U.S. Food and Drug Administration (FDA) has granted approval for Pfizer's RSV vaccine, Abrysvo, aimed at preventing lower respiratory tract disease caused by respiratory syncytial virus (RSV) in adults aged 18 to 59 who are
Nine (2.48%) women out of 362 were screen positive for chromosomopathy Ground-breaking Research on Prenatal Screening for Chromosomal Anomalies Redcliffe Labs, a leading omni-channel Pan India diagnostics service provider, has come out with an comprehensive research study on prenatal screening for chromosomal anomalies. Led by Dr. Sohini
